Biosensors for the detection of bacterial and viral clinical pathogens
L Castillo-Henríquez, M Brenes-Acuña, A Castro-Rojas… - Sensors, 2020 - mdpi.com
Biosensors are measurement devices that can sense several biomolecules, and are widely
used for the detection of relevant clinical pathogens such as bacteria and viruses, showing …
used for the detection of relevant clinical pathogens such as bacteria and viruses, showing …
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus
J Li, S Li, L Yang, P Cao, J Lu - Critical Reviews in Microbiology, 2021 - Taylor & Francis
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel bunyavirus. Since
2007, SFTS disease has been reported in China with high fatality rate up to 30%, which …
2007, SFTS disease has been reported in China with high fatality rate up to 30%, which …
Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey
Background The current outbreak of Ebola in eastern DR Congo, beginning in 2018,
emerged in a complex and violent political and security environment. Community-level …
emerged in a complex and violent political and security environment. Community-level …
Pandemics–One Health preparedness for the next
FM Aarestrup, M Bonten, M Koopmans - The Lancet Regional Health …, 2021 - thelancet.com
The majority of emerging infectious diseases originate in animals. Current routine
surveillance is focused on known diseases and clinical syndromes, but the increasing …
surveillance is focused on known diseases and clinical syndromes, but the increasing …
Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined …
D Ishola, D Manno, MO Afolabi, B Keshinro… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background The Ebola epidemics in west Africa and the Democratic Republic of
the Congo highlight an urgent need for safe and effective vaccines to prevent Ebola virus …
the Congo highlight an urgent need for safe and effective vaccines to prevent Ebola virus …
Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach
M Alizadeh, H Amini-Khoei, S Tahmasebian… - Scientific reports, 2022 - nature.com
Ebola virus (EBOV) is a dangerous zoonotic infectious disease. To date, more than 25 EBOV
outbreaks have been documented, the majority of which have occurred in Central Africa …
outbreaks have been documented, the majority of which have occurred in Central Africa …
Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus
Ebola virus (EBOV), a member of the family Filoviridae, is responsible for causing Ebola
virus disease (EVD)(formerly named Ebola hemorrhagic fever). This is a severe, often fatal …
virus disease (EVD)(formerly named Ebola hemorrhagic fever). This is a severe, often fatal …
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
Q Cui, R Du, M Anantpadma, A Schafer, L Hou, J Tian… - Viruses, 2018 - mdpi.com
The recent 2014–2016 West African Ebola virus epidemic underscores the need for the
development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus …
development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus …
Politicizing public health: The powder keg of rushing COVID-19 vaccines
Vaccine hesitancy is on the rise, as more individuals are delaying or refusing vaccines. This
rise in hesitancy has been primarily driven by vaccine safety concerns, even though the …
rise in hesitancy has been primarily driven by vaccine safety concerns, even though the …
Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal …
Background Whether or not individuals with pauci-symptomatic or asymptomatic Ebola virus
infection and unrecognised Ebola virus disease develop clinical sequelae is unknown. We …
infection and unrecognised Ebola virus disease develop clinical sequelae is unknown. We …